Emcure expands injectables capacity, opens 3rd facility in Gujarat
时间:2024-06-25 14:24:51 阅读(143)
The third injectable facility of Emcure Pharmaceuticals in Mehsana, Gujarat, which was commissioned in August 2023, is now ready for commercial supplies to domestic and international markets. The company already has an oral formulations manufacturing line in Mehsana.
It also has a facility in Hinjawadi, Pune, with a capacity of 80.64 million vials per annum and another in Sanand, Gujarat, with a capacity to churn out 72 million vials per annum.
IPO-bound Emcure’s manufacturing operations cover oral solids, oral liquids and injectables, including liposomal and lyophilized injectables, biotherapeutics and complex APIs. The company’s subsidiary Gennova Biopharmaceuticals,also plans to use its mRNA platform, through which it launched the Covid-19 vaccine, forthree other vaccines for Zoster, Zika and Rabies.
Emcure’s injectable portfolio includes complex iron injectables, oncology, steroids, suspensions and emulsions. Emcure can produce high-potency injectables, particularly oncology products.
Emcure had filed a draft red herring prospectus (DRHP) on December 16 for its Rs 800 crore IPO. It is the 12th largest Indian pharmaceutical company and the largest pharmaceutical company in the gynaecology, blood-related and HIV antiviral therapeutics segment in the country.
For the international markets, the firm’s focus is on developing and commercialising products, which requires significant expertise and is subject to less competition and offers higher margins.
In Europe and other key target markets, they are focused on higher-value-added generics and complex injectables, such as Cidofovir and Meropenem. Europe is one of the focus areas in the hospital segment, as it is a large market for complex injectables products, such as Cidofovir, BiCNU and Treprostinil, the company’s DRHP said.
The company is working on `ready-to-use’ products that reduce multi-step dose preparation and enable ease of use by physicians.
猜你喜欢
- Cyclone Biparjoy is coming! Heavy rains lash Gujarat – See pics
- Commerce and Industry Minister Piyush Goyal likely to chair Board of Trade meeting next month; ways to boost trade on agenda
- Capital market regulator Sebi relaxes rules for govt for PSU disinvestment
- NSE Bulk Deals, July 21- Reliance Power, Reliance Infra, Bandhan Bank, other major deals from previous session
- Buy these 2 shares for gains; Nifty in down-trend, may fall to 17613 if it breaks 17820-17798
- Crude oil price on track for biggest monthly gains in over a year
- NSE Bulk deals, July 13- CSB Bank, PC Jeweller, Cell Point, Delta Corp, other major deals that took place on Thursday
- Chandresh Nigam leaves Axis MF, Gopkumar to succeed
- Can I drink water while standing- How much water should I drink daily- Here’s your ultimate guide certified by experts